HUANG ET AL.
3
from CH2Cl2–diethyl ether. The desired complex was
obtained as an orange solid (75 mg, 70%). 1H NMR
(400 MHz, CDCl3, δ, ppm): 8.66 (d, J = 8.2 Hz, 1H, NP‐
H), 8.47–8.38 (m, 2H, NP‐H), 7.91 (s, 1H, Im‐H), 7.62
(d, J = 8.2 Hz, 1H, NP‐H), 6.99 (s, 2H, Ar‐H), 6.90 (s, 1H,
Im‐H), 6.03 (d, J = 15.4 Hz, 1H, CH2), 5.60 (d,
J = 15.4 Hz, 1H, CH2), 5.31–5.14 (m, 1H, allyl‐H), 4.45
(d, J = 6.4 Hz, 1H, allyl‐H), 3.88 (d, J = 14.1 Hz, 1H,
allyl‐H), 3.02 (d, J = 6.4 Hz, 1H, allyl‐H), 2.35 (s, 3H,
─Me), 1.98 (s, 3H, ─Me), 1.95 (s, 1H, allyl‐H), 1.89
(s, 3H, ─Me). 13C NMR (100 MHz, CD2Cl2, δ, ppm):
178.8 (Pd═C), 160.1, 155.4, 153.4, 141.7, 140.6, 139.6,
135.9, 135.4, 134.8, 129.2, 129.0, 125.6, 124.8, 123.2, 122.2
(aromatic‐C), 117.1 (allyl), 77.2 (allyl), 55.5 (CH2), 47.3
(allyl), 20.9, 17.8, 17.6. Anal. Calcd for C24H24BClF4N4Pd
(%): C, 48.27; H, 4.05; N, 9.38. Found (%): C, 48.03;
H, 4.11; N, 9.34.
J = 2.0 Hz, 1H, Im‐H), 7.01 (s, 1H, Ar‐H), 6.90 (s, 1H, Ar‐
H), 6.75 (d, J = 2.0 Hz, 1H, Im‐H), 6.31 (d, J = 15.0 Hz,
1H, ─CH2), 6.08 (d, J = 15.0 Hz, 1H, ─CH2), 4.53–4.38
(m, 2H, COD), 2.88 (br, 1H, COD), 2.74 (br, 1H, COD),
2.34 (s, 3H, ─Me), 2.33 (s, 3H, ─Me), 2.06–1.95 (m, 2H,
COD), 1.92 (s, 3H, ─Me), 1.87–1.72 (m, 2H, COD), 1.57–
1.45 (m, 2H, COD), 1.45–1.32 (m, 2H, COD). 13C NMR
(100 MHz, δ, ppm): 181.0 (Ir═C), 161.5, 154.9, 154.3,
139.3, 138.7, 137.8, 136.7, 135.7, 134.3, 129.5, 128.2,
123.9, 123.5, 123.0, 121.3, 120.8 (aromatic‐C), 84.0
(COD), 83.9 (COD), 56.6 (CH2), 52.3 (COD), 51.4 (COD),
34.3 (COD), 32.5 (COD), 29.4 (COD), 28.7 (COD), 21.0,
19.5, 18.0. ESI‐HRMS for [M − Cl]+ m/z = calcd 663.1867
(C29H31N4ClIr). Found: 663.1866. Anal. Calcd for
C29H31Cl2IrN4 (%): C, 49.85; H, 4.47; N, 8.02. Found (%):
C, 49.53; H, 4.12; N, 7.82.
2.8 | Preparation of [Rh(COD)(C,N‐NpNHC)](BF4)
(7a)
2.6 | Preparation of [RhCl(COD)(C‐NpNHC)] (6a)
A mixture of 4 (105 mg, 0.1 mmol) and [Rh(COD)Cl]2
(55 mg, 0.1 mmol) in CH2Cl2 (10 ml) was stirred at ambient
temperature overnight. The reaction mixture was filtered
through celite and the filtrate was concentrated. The residue
was re‐precipitated from CH2Cl2–hexane. The desired com-
plex was obtained as a yellow solid (111 mg, 95%). 1H
NMR (400 MHz, CDCl3, δ, ppm): 8.24 (d, J = 8.2 Hz, 1H,
NP‐H), 8.15 (d, J = 8.4 Hz, 1H, NP‐H), 8.11 (d,
J = 8.2 Hz, 1H, NP‐H), 7.49 (d, J = 8.4 Hz, 1H, NP‐H),
7.16 (s, 1H, Im‐H), 7.07 (s, 1H, Ar‐H), 6.90 (s, 1H, Ar‐H),
6.75 (s, 1H, Im‐H), 6.56 (d, J = 15.0 Hz, 1H, ─CH2), 6.18
(d, J = 15.0 Hz, 1H, ─CH2), 4.86 (br, 1H, COD), 4.80 (br,
1H, COD), 3.28 (br, 1H, COD), 3.00 (br, 1H, COD), 2.42
(s, 3H, ─Me), 2.35 (s, 3H, ─Me), 2.17–2.04 (m, 2H,
COD), 2.04–1.92 (m, 2H, COD), 1.85 (s, 3H, ─Me), 1.77–
1.63 (m, 2H, COD), 1.58–1.38 (m, 2H, COD). 13C NMR
(100 MHz, δ, ppm): 183.2 (d, JRh─C = 51.6 Hz, Rh═C),
161.5, 154.7, 154.1, 139.1, 138.5, 137.7, 136.8, 135.7,
134.1, 129.4, 128.1, 123.7, 123.6, 123.0, 121.4, 120.7 (aro-
matic‐C), 97.6 (br, COD‐C), 68.8 (d, JRh─C = 14.7 Hz,
COD‐C), 67.7 (d, JRh─C = 14.2 Hz, COD‐C), 57.1 (CH2),
34.0 (COD‐C), 31.6 (COD‐C), 29.1 (COD‐C), 28.1 (COD‐
C), 21.2 (CH3), 19.9 (CH3), 18.1 (CH3). HR‐HRMS for
[M − Cl]+ m/z = calcd 573.1292 (C29H31N4ClRh). Found:
573.1286. Anal. Calcd for C29H31Cl2N4Rh(CHCl3) (%): C,
49.44; H, 4.43; N, 7.69. Found (%): C, 49.71; H, 4.46; N,
7.79.
A mixture of 6a (111 mg, 0.2 mmol) and AgBF4 (49 mg,
0.2 mmol) in CH2Cl2 (10 ml) was stirred under nitrogen
atmosphere at ambient temperature overnight. The reaction
mixture was filtered through celite and the filtrate was con-
centrated. The residue was re‐precipitated from CH2Cl2–hex-
ane. The desired complex was obtained as an orange solid
1
(118 mg, 98%). H NMR (400 MHz, CDCl3, δ, ppm): 8.65
(d, J = 8.2 Hz, 1H, NP‐H), 8.47 (d, J = 8.5 Hz, 1H, NP‐
H), 8.32 (d, J = 8.2 Hz, 1H, NP‐H), 7.71 (d, J = 1.6 Hz,
1H, Im‐H), 7.58 (d, J = 8.5 Hz, 1H, NP‐H), 7.08 (s, 1H,
Ar‐H), 6.95 (s, 1H, Ar‐H), 6.69 (d, J = 1.6 Hz, 1H, Im‐H),
6.31 (d, J = 14.9 Hz, 1H, ─CH2), 6.19 (d, J = 14.9 Hz,
1H, ─CH2), 5.80–5.69 (m, 1H, COD), 4.45–4.31 (m, 1H,
COD), 3.99 (br, 1H, COD), 3.10 (br, 1H, COD), 2.64–2.41
(m, 1H, COD), 2.36 (s, 3H, ─Me), 2.29–2.16 (m, 3H,
COD), 2.15–2.03 (m, 2H, COD), 1.97 (s, 3H, ─Me), 1.95
(s, 3H, ─Me), 1.75–1.61 (m, 2H, COD). 13C NMR
(100 MHz, δ, ppm): 179.0 (d, JRh─C = 51.5 Hz, Rh═C),
161.2, 154.6, 153.7, 141.3, 140.9, 139.1, 135.6, 135.0,
134.1, 129.8,129.5, 129.1, 125.2, 124.6, 123.0, 122.2 (aro-
matic‐C), 100.9 (COD), 99.6 (COD), 74.1 (d,
JRh─C = 14.9 Hz, COD), 71.0 (d, JRh─C = 12.7 Hz, COD),
56.3 (CH2), 34.0 (COD), 30.7 (COD), 29.7 (COD), 27.2
(COD), 21.1 (CH3), 18.9 (CH3), 17.9 (CH3). ESI‐HRMS
for [M]+ m/z = calcd 573.1292 (C29H31N4ClRh). Found:
573.1297. Anal. Calcd for C29H31BCl F4N4Rh(CH2Cl2)
(%): C, 48.32; H, 4.46; N, 7.51. Found (%): C, 48.41; H,
4.67; N, 7.81.
2.7 | Preparation of [IrCl(COD)(C‐NpNHC)] (6b)
2.9 | Preparation of [Ir(COD)(C,N‐NpNHC)](BF4) (7b)
The procedure for the preparation of 6b was similar to that for
6a, affording a yellow solid (132 mg, 96%). 1H NMR
(400 MHz, CDCl3, δ, ppm): 8.24 (d, J = 8.3 Hz, 1H, NP‐
H), 8.15 (d, J = 8.4 Hz, 1H, NP‐H), 8.07 (d, J = 8.3 Hz,
1H, NP‐H), 7.51 (d, J = 8.4 Hz, 1H, NP‐H), 7.24 (d,
The procedure for the preparation of 7b was similar to that for
7a, affording an orange solid (78 mg, 93%). 1H NMR
(400 MHz, CDCl3, δ, ppm): 8.69 (d, J = 8.3 Hz, 1H, NP‐
H), 8.52 (d, J = 8.3 Hz, 1H, NP‐H), 8.31 (d, J = 8.3 Hz,